Vural, Mustafa GokhanTemel, Hulya YilmazTurunc, EzgiAkdemir, RamazanTatli, ErsanAgac, Mustafa Tarik2024-08-312024-08-3120241010-660X1648-9144https://doi.org/10.3390/medicina60040590https://hdl.handle.net/11454/104514Background and Objectives: In this present study, we investigated the impact of mechanosensitive microRNAs (mechano-miRs) on the collateral development in 126 chronic total occlusion (CTO) patients, selected from 810 undergoing angiography. Materials and Methods: We quantified the collateral blood supply using the collateral flow index (CFI) and assessed the transcoronary mechano-miR gradients. Results: The patients with favorable collaterals had higher CFI values (0.45 +/- 0.02) than those with poor collaterals (0.38 +/- 0.03, p < 0.001). Significant differences in transcoronary gradients were found for miR-10a, miR-19a, miR-21, miR-23b, miR-26a, miR-92a, miR-126, miR-130a, miR-663, and let7d (p < 0.05). miR-26a and miR-21 showed strong positive correlations with the CFI (r = 0.715 and r = 0.663, respectively), while let7d and miR-663 were negatively correlated (r = -0.684 and r = -0.604, respectively). The correlations between cytokine gradients and mechano-miR gradients were also significant, including Transforming Growth Factor Beta with miR-126 (r = 0.673, p < 0.001) and Vascular Endothelial Growth Factor with miR-10a (r = 0.602, p = 0.002). A regression analysis highlighted the hemoglobin level, smoking, beta-blocker use, miR-26a, and miR-663 as significant CFI determinants, indicating their roles in modulating the collateral vessel development. Conclusions: These findings suggest mechanosensitive microRNAs as predictive biomarkers for collateral circulation, offering new therapeutic perspectives for CTO patients.en10.3390/medicina60040590info:eu-repo/semantics/openAccessChronic Total OcclusionCollateral Flow IndexMechanosensitive MicrornasTranscoronary GradientCoronary Collateral DevelopmentCytokinesTranscoronary Gradients of Mechanosensitive MicroRNAs as Predictors of Collateral Development in Chronic Total OcclusionArticle604WOS:0012112232000012-s2.0-8519133441338674237Q2N/A